Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Absci (ABSI) Cash & Equivalents (2020 - 2025)

Absci's Cash & Equivalents history spans 6 years, with the latest figure at $9.5 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 75.19% year-over-year to $9.5 million; the TTM value through Sep 2025 reached $9.5 million, down 75.19%, while the annual FY2024 figure was $41.2 million, 43.05% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $9.5 million at Absci, down from $38.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $279.3 million in Q3 2021 and bottomed at $9.5 million in Q3 2025.
  • The 5-year median for Cash & Equivalents is $54.4 million (2022), against an average of $82.7 million.
  • The largest annual shift saw Cash & Equivalents crashed 94.95% in 2023 before it soared 415.65% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $252.6 million in 2021, then crashed by 76.26% to $60.0 million in 2022, then grew by 20.69% to $72.4 million in 2023, then plummeted by 43.05% to $41.2 million in 2024, then crashed by 77.01% to $9.5 million in 2025.
  • Per Business Quant, the three most recent readings for ABSI's Cash & Equivalents are $9.5 million (Q3 2025), $38.0 million (Q2 2025), and $47.0 million (Q1 2025).